Sicart Associates’s Cameco CCJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17,300
Closed -$503K 84
2022
Q1
$503K Sell
17,300
-13,050
-43% -$306K 0.13% 54
2021
Q4
$662K Sell
30,350
-3,050
-9% -$73.8K 0.17% 55
2021
Q3
$726K Sell
33,400
-425
-1% -$8.04K 0.2% 54
2021
Q2
$649K Buy
33,825
+4,600
+16% +$86.8K 0.15% 62
2021
Q1
$485K Buy
29,225
+12,225
+72% +$188K 0.13% 69
2020
Q4
$228K Buy
+17,000
New +$182K 0.06% 103
2017
Q2
Sell
-12,500
Closed -$138K 79
2017
Q1
$138K Sell
12,500
-17,500
-58% -$200K 0.1% 87
2016
Q4
$314K Buy
+30,000
New +$271K 0.22% 86

Other funds holding CCJ

Sicart Associates's CCJ Position: Q2 2022 in Review

Sicart Associates sold out of Cameco (CCJ) in Q2 2022, closing a stake of 17,300 shares — an estimated $503K sold.

Sicart Associates first reported a position in CCJ in Q4 2016 and held it in 8 quarters. The position peaked at $726K in Q3 2021. 415 funds tracked by Wall St. Rank hold CCJ as of Q2 2022.

  • Sicart Associates reported no remaining Cameco position as of Q2 2022 after selling out during the quarter.
  • Sicart Associates sold 17,300 Cameco shares in Q2 2022, an estimated $503K.
  • Sicart Associates first reported a position in Cameco in Q4 2016 and held it in 8 quarters.
  • Sicart Associates's Cameco position peaked at $726K in Q3 2021.
  • 415 funds tracked by Wall St. Rank held Cameco as of Q2 2022.

Based on Sicart Associates's 13F filing for Q2 2022, filed 5 Aug 2022.